Login
Home
Charts
Search
Watchlist
Products

BASF India Ltd

BASF·NSE
3,572.20-2.50%Tue, 22 Sept '26 15:54

BASF India Ltd

BASF
NSE
3,572.20
-2.50%
|Tue, 22 Sept '26 15:54
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
15,485Cr
Close
Close Price
3,577.50
Industry
Industry
Chemicals - Organic
PE
Price To Earnings
24.09
PS
Price To Sales
0.97
Revenue
Revenue
16,027Cr
Rev Gr TTM
Revenue Growth TTM
6.53%
PAT Gr TTM
PAT Growth TTM
62.42%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2020Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
2,5073,3263,3603,9674,2483,6353,2873,8753,8963,8633,4444,824
Growth YoY
Revenue Growth YoY%
24.49.3-2.2-2.3-8.36.34.824.5
Expenses
ExpensesCr
2,2673,1143,1143,6544,0473,4653,2373,6613,7413,6933,3334,320
Operating Profit
Operating ProfitCr
24021224631220117050214155170111504
OPM
OPM%
9.66.47.37.94.74.71.55.54.04.43.210.5
Other Income
Other IncomeCr
62725361819351925111122
Interest Expense
Interest ExpenseCr
633534457525
Depreciation
DepreciationCr
434948474545414137343741
PBT
PBTCr
1971872192971711404118813514283480
Tax
TaxCr
8147587643351450353621132
PAT
PATCr
1151401612211281042713710710769360
Growth YoY
PAT Growth YoY%
455.6-26.1-83.3-37.7-16.23.0155.0162.2
NPM
NPM%
4.64.24.85.63.02.90.83.52.82.82.07.5
EPS
EPS
26.632.337.351.029.624.26.231.724.824.416.083.3
QuarterDec 2020Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
2,5073,3263,3603,9674,2483,6353,2873,8753,8963,8633,4444,824
Growth YoY
Revenue Growth YoY%
24.49.3-2.2-2.3-8.36.34.824.5
Expenses
ExpensesCr
2,2673,1143,1143,6544,0473,4653,2373,6613,7413,6933,3334,320
Operating Profit
Operating ProfitCr
24021224631220117050214155170111504
OPM
OPM%
9.66.47.37.94.74.71.55.54.04.43.210.5
Other Income
Other IncomeCr
62725361819351925111122
Interest Expense
Interest ExpenseCr
633534457525
Depreciation
DepreciationCr
434948474545414137343741
PBT
PBTCr
1971872192971711404118813514283480
Tax
TaxCr
8147587643351450353621132
PAT
PATCr
1151401612211281042713710710769360
Growth YoY
PAT Growth YoY%
455.6-26.1-83.3-37.7-16.23.0155.0162.2
NPM
NPM%
4.64.24.85.63.02.90.83.52.82.82.07.5
EPS
EPS
26.632.337.351.029.624.26.231.724.824.416.083.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2020Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6838471,0591,3241,6357,59513,76714,78014,94416,027
Growth
Revenue Growth%
24.025.125.023.57.41.16.5
Expenses
ExpensesCr
5937569491,2131,4557,31612,87814,05014,28415,086
Operating Profit
Operating ProfitCr
9090110111180279890730660941
OPM
OPM%
13.110.710.38.411.03.76.54.94.45.9
Other Income
Other IncomeCr
52000-4761086669
Interest Expense
Interest ExpenseCr
234728316151920
Depreciation
DepreciationCr
2212151728181191170145149
PBT
PBTCr
7078918815110759653561841
Tax
TaxCr
2528343955-13196169145224
PAT
PATCr
455057499623563484416643
Growth
PAT Growth%
10.514.8-15.497.6-14.1-14.062.4
NPM
NPM%
6.65.95.43.75.90.34.13.32.84.0
EPS
EPS
16.117.820.417.224.85.3130.1110.797.1148.5
Financial YearMar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2020Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6838471,0591,3241,6357,59513,76714,78014,94416,027
Growth
Revenue Growth%
24.025.125.023.57.41.16.5
Expenses
ExpensesCr
5937569491,2131,4557,31612,87814,05014,28415,086
Operating Profit
Operating ProfitCr
9090110111180279890730660941
OPM
OPM%
13.110.710.38.411.03.76.54.94.45.9
Other Income
Other IncomeCr
52000-4761086669
Interest Expense
Interest ExpenseCr
234728316151920
Depreciation
DepreciationCr
2212151728181191170145149
PBT
PBTCr
7078918815110759653561841
Tax
TaxCr
2528343955-13196169145224
PAT
PATCr
455057499623563484416643
Growth
PAT Growth%
10.514.8-15.497.6-14.1-14.062.4
NPM
NPM%
6.65.95.43.75.90.34.13.32.84.0
EPS
EPS
16.117.820.417.224.85.3130.1110.797.1148.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
434343
Reserves
ReservesCr
3,1803,5913,914
Current Liabilities
Current LiabilitiesCr
3,8274,6264,275
Non Current Liabilities
Non Current LiabilitiesCr
183202203
Total Liabilities
Total LiabilitiesCr
7,2338,4628,436
Current Assets
Current AssetsCr
6,0977,1997,225
Non Current Assets
Non Current AssetsCr
1,1361,2631,210
Total Assets
Total AssetsCr
7,2338,4628,436
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
434343
Reserves
ReservesCr
3,1803,5913,914
Current Liabilities
Current LiabilitiesCr
3,8274,6264,275
Non Current Liabilities
Non Current LiabilitiesCr
183202203
Total Liabilities
Total LiabilitiesCr
7,2338,4628,436
Current Assets
Current AssetsCr
6,0977,1997,225
Non Current Assets
Non Current AssetsCr
1,1361,2631,210
Total Assets
Total AssetsCr
7,2338,4628,436

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
807373-110
Investing Cash Flow
Investing Cash FlowCr
-450-114379
Financing Cash Flow
Financing Cash FlowCr
-102-129-179
Net Cash Flow
Net Cash FlowCr
25513189
Free Cash Flow
Free Cash FlowCr
708202-310
CFO To PAT
CFO To PAT%
143.377.0-26.4
CFO To EBITDA
CFO To EBITDA%
90.751.0-16.7
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
807373-110
Investing Cash Flow
Investing Cash FlowCr
-450-114379
Financing Cash Flow
Financing Cash FlowCr
-102-129-179
Net Cash Flow
Net Cash FlowCr
25513189
Free Cash Flow
Free Cash FlowCr
708202-310
CFO To PAT
CFO To PAT%
143.377.0-26.4
CFO To EBITDA
CFO To EBITDA%
90.751.0-16.7

Ratios

Consolidated
Standalone
Financial YearMar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2020Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6215395495041,4454,86614,44419,18213,91515,485
Price To Earnings
Price To Earnings
11.115.9212.925.640.033.124.1
Price To Sales
Price To Sales
0.90.60.50.40.90.61.11.30.91.0
Price To Book
Price To Book
1.41.73.94.55.33.53.9
EV To EBITDA
EV To EBITDA
15.725.420.015.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.612.313.113.1
OPM
OPM%
13.110.710.38.411.03.76.54.94.45.9
NPM
NPM%
6.65.95.43.75.90.34.13.32.84.0
ROCE
ROCE%
22.917.514.214.2
ROE
ROE%
17.513.310.510.5
ROA
ROA%
7.85.74.94.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2020Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6215395495041,4454,86614,44419,18213,91515,485
Price To Earnings
Price To Earnings
11.115.9212.925.640.033.124.1
Price To Sales
Price To Sales
0.90.60.50.40.90.61.11.30.91.0
Price To Book
Price To Book
1.41.73.94.55.33.53.9
EV To EBITDA
EV To EBITDA
15.725.420.015.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.612.313.113.1
OPM
OPM%
13.110.710.38.411.03.76.54.94.45.9
NPM
NPM%
6.65.95.43.75.90.34.13.32.84.0
ROCE
ROCE%
22.917.514.214.2
ROE
ROE%
17.513.310.510.5
ROA
ROA%
7.85.74.94.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
BASF India is the local arm of the German chemical giant that has been quietly embedding itself into the Indian economy for over 80 years - its molecules end up in car bumpers, crop sprays, vitamin tablets, house paint, and the soles of your shoes. Incorporated in 1943, the company shifted its operating model in 2019 from acting as a sales agent for its parent to a full-fledged merchant that owns inventory and sells directly, and today it balances a portfolio that is roughly half goods it manufactures in India and half goods it trades. The recurring logic behind every move - from building a new dispersion line in Mangalore to spinning off the agricultural business into a separate listed company - is a patient, scale-first approach: it will “premarket” a product for years, building demand until Indian volumes justify a local factory rather than running a plant at 20% utilisation. # Business segments Five engines at different stages - a materials cash cow, two consumer-facing platforms at national scale, a traded-chemicals bridge, and a coatings business just sold - each built with the cash flows of the one before. ## 1. Materials: the industrial backbone that carries the company **Polyurethanes and engineering plastics that go into everything from car suspensions to refrigerator insulation, where BASF holds a commanding position in several niches.** - **Dominant in jounce bumpers** - the company has a “very, very strong market share” in these microcellular polyurethane components that cushion car suspensions, and it has just completed a new building to expand local production of them. - **A new plant for a signature material** - Cellasto®, the brand under which those jounce bumpers and other vibration-damping parts are sold, saw a capacity expansion at Dahej break ground in January 2025 and finish construction by May 2026. - **Bought its way into engineering plastics** - the 2020 acquisition of BASF Performance Polyamides India (formerly Rhodia) brought the Panoli site and the Technyl® brand into the fold, adding a wide range of engineering plastics for automobiles and electrical goods; the merger that followed strengthened the Materials segment through backward integration into key raw materials. - **A lab to co-develop with customers** - a Polyurethane Technical Development Centre in Navi Mumbai, inaugurated in May 2024, lets the company sit side-by-side with footwear and furniture makers to tailor formulations using state-of-the-art application equipment. - **Sells directly to small buyers online** - it launched an e-commerce channel, mypu.basf.com, specifically for polyurethane products aimed at the footwear and furniture industry, creating a new route to market beyond traditional distribution. ## 2. Agricultural Solutions: a pure-play crop protection company in the making **A business that reaches 150 million farmers through 200,000 retailers and is being demerged into its own listed entity so it can compete head-to-head with Syngenta, Bayer, and UPL.** - **Twelve new products in four years** - launches like Exponus (for chewing pests) and Efficon (for sucking pests) now represent roughly a quarter of the segment’s total sales, with Exponus alone hitting Rs. 100 crores within 130 days of launch. - **A distribution machine built for Indian agriculture** - the company works with more than 1,700 distribution partners who feed a chain of over 10,000 wholesalers and roughly 200,000 retailers, placing products close to application timing so inventory can be shifted to where pest or disease pressure actually appears. - **Farmer training at massive scale** - the “Suraksha Hamesha” stewardship programme has cumulatively trained nearly a million farmers, over 46,000 women farmers, and more than 133,000 spray operators in the safe use of agrochemicals over the past decade, with a digital outreach of about 60 million. - **The demerger unlocks focus** - the agricultural business is being carved into a separate listed company, BASF Agricultural Solutions India Ltd, with a 1:1 share ratio, so it can attract its own capital allocation and gain the visibility of a standalone pure-play agrochemical firm; listing is expected between January and March 2027. ## 3. Nutrition & Care: the ingredients platform behind consumer goods **Vitamins, cosmetic actives, and aroma chemicals that supply the personal-care, pharmaceutical, and food-fortification industries - a business built on specialty molecules rather than bulk commodities.** - **From skin creams to bread** - the Care Chemicals side supplies surfactants and emulsifiers to shampoo and detergent makers, while Nutrition & Health provides vitamins and carotenoids to food companies, including partnering with the government’s Food Fortification Initiative. - **A probiotic for wrinkles** - one of the segment’s differentiated offerings is Probiolift™, a cosmetic ingredient containing live probiotics that targets skin fullness and wrinkle improvement, illustrating the shift toward high-value bioactives. - **Pharma excipients with a pandemic legacy** - the Pharma Solutions team worked with leading Indian pharmaceutical companies to develop new formulations and supplied critical excipients used in COVID-19 treatments, building relationships that outlasted the crisis. - **A fragrance co-developed with outsiders** - Velberry™ is a new fragrance ingredient and the first substance developed jointly by BASF and its innovation ecosystem partners for the broad market, signalling an open-innovation approach in aroma chemicals. ## 4. Chemicals: the traded bridge to upstream raw materials **A purely merchandise business that imports petrochemicals and intermediates - the building blocks for pharma, paints, and adhesives - without owning a single reactor in India.** - **The world’s largest intermediates portfolio, sold in India** - the Intermediates division markets over 700 products, including chiral auxiliaries and protective groups that pharmaceutical companies use as starting materials for drug synthesis. - **A biodegradable acid for bread and feed** - the company is the leading producer of Propionic Acid, a mould inhibitor used in food preservation and grain storage, as well as in making crop protection agents and pharmaceuticals. - **A non-phthalate plasticizer for safer PVC** - Hexamoll® DINCH is an innovative plasticizer used in flexible PVC applications like artificial leather for car upholstery and food-packaging cling film, offering an alternative to conventional phthalates. - **Under pressure from China** - both the Petrochemicals and Intermediates businesses face severe price competition from Chinese suppliers, making this a volume-and-relationship game rather than a margin story. ## 5. Surface Technologies: the coatings business that was sold **Automotive paints for Maruti, Tata, and Mahindra - transferred to a Carlyle-led global standalone company in mid-2026, with BASF India retaining no direct operating role.** - **E-coat for corrosion protection** - the company expanded its “ecode” base-layer coating capacity at Mangalore, completed in April 2024, to serve automotive manufacturers across India, South Asia, and ASEAN. - **Deep ties with carmakers** - it ran “Tech Days” at Maruti Suzuki and had a joint CSR project with Mahindra & Mahindra to train underprivileged women in paint-shop skills, embedding itself in customers’ operations beyond just supplying paint. - **Exited via a global deal** - the coatings business was first moved into a wholly owned subsidiary in January 2025, then the entire stake was sold to Carlyle group companies on June 30, 2026, for Rs. 230.16 crore, as part of a global transaction valuing the combined coatings operations at €7.7 billion. # Group structure and partners **A subsidiary of BASF SE with deep operational dependence on the parent for raw materials and technology, but with its own listed identity and a growing local manufacturing footprint.** - **Four-fifths of raw materials come from group companies** - related-party purchases account for 79% of total purchases, meaning the Indian entity is tightly integrated into the global supply chain of the BASF group. - **Technical know-how flows from the parent** - the company has agreements with BASF SE and its group companies for sourcing technology in Performance Materials, Care Chemicals, and formerly Construction Products and Coatings, giving it access to formulations and processes developed with the parent’s roughly €2 billion annual R&D spend. - **A new global services hub in Hyderabad** - BASF Group is setting up two hubs in India: a Global Business Services centre for HR and finance, and a Digital Solutions hub, signalling that India’s role in the group extends beyond manufacturing and sales. - **Renewable power for the factories** - the company acquired a 26% stake in a Clean Max special-purpose vehicle to procure about 28,860 MWh annually of wind-solar hybrid power for its Dahej and Panoli sites under a 25-year agreement, part of the group’s push toward a 30% CO₂ reduction by 2030.

Documents — BASF India Ltd

  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/fjqr56wqrxa5i85lkiupdpnn.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/i8zf4ca27njzczg62rqb4kox.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/awmkxh4n4nwtuqln0ez9mmnj.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/9wwop14gvys7nmrrguvk09v7.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/mam5l5f1g6xgsapsirf8urw4.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/ewijc53x9s080bxfgohnupjs.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/rt5ap4kmtia1k6s1p22gccsn.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/qb52y1gbl0t3sa3c174j4wo6.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/p5jdhb89afygbwrj1heb6wo7.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/4z6rrgc0hi7jcmug1kyv3wk0.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/tjnbs88ae20ti23rkv8w0a59.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/7dlc4pg0p7oqtls828ldcv8f.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/exag84u68ac3y7jwoh5j7mtf.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/4383o9jae00uy04et3qm4k5t.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/rj4y5gd0oplbho8fevitr79g.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/mvzm3fwru5a0sgjg1av7qfp0.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/fnlpo6jorx78rh0ac7edfsay.pdf
  • Q1 FY2025 Investor Presentation (Jun 2024, PDF): https://www.stockscans.in/document/idkqy87rz7vq4hg0bblab7fd.pdf
  • Q4 FY2024 Investor Presentation (Mar 2024, PDF): https://www.stockscans.in/document/md1mq77ae53b70ya6p5pc1nn.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/xig2fe17b8y8nsyye5st30su.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/cghs5dzhxs9a08zpm615pj33.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/wlm759cxli920xe9a7wfin3w.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/p8ncqzqn3vurei7nd7yrvsgr.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/k9ue7nd9yawtcnddvbq0m1ai.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/ymldphwp3xocz7ldikn6kyra.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/vl8iyhqb8o7ha6q0pbznkazv.pdf

Concall Transcript Summaries — BASF India Ltd

  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ABASF/transcript-notes/202603/fjqr56wqrxa5i85lkiupdpnn.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ABASF/transcript-notes/202509/i8zf4ca27njzczg62rqb4kox.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ABASF/transcript-notes/202503/awmkxh4n4nwtuqln0ez9mmnj.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ABASF/transcript-notes/202409/9wwop14gvys7nmrrguvk09v7.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3ABASF/transcript-notes/202403/mam5l5f1g6xgsapsirf8urw4.pdf